Equities research analysts at Raymond James boosted their FY2025 earnings per share (EPS) estimates for Medexus Pharmaceuticals in a report released on Monday, February 3rd. Raymond James analyst M.

Stock analysts at Raymond James boosted their Q4 2024 earnings per share (EPS) estimates for Agnico Eagle Mines in a research note issued to investors on Monday, February 3rd. Raymond James analyst F.

Cooper Webb is the defending Tampa winner. The four favorites to win the championship all finished in the top five.

James initiated coverage on Regenxbio Inc . (NASDAQ:RGNX), bestowing an Outperform rating and setting a price target of $27.00 for the biotechnology company's shares. The firm's endorsement comes with ...

This was the stock's second consecutive day of gains.

Shares of Amazon (NASDAQ: AMZN) gained 1.13% on Thursday before falling off a cliff after the close despite the company ...

Apple (AAPL) supplier Skyworks Solutions (SWKS) saw its stock drop more than 23% Thursday as the semiconductor firm said that ...

January finished with an earthquake in the tech world, when the Chinese startup DeepSeek released its new AI assistant – and ...

LPL Financial welcomes a $345 million investment and planning team from Ameriprise as RayJay's employee advisor arm adds a ...

Raymond James Financial, a leading financial services company, has announced its robust first-quarter performance for Fiscal ...